Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
activities of daily living
advances in neurology
adverse drug reaction
akathisia
albumin
alcohol
alcoholism
alpha-synuclein
alternative medicine
Alzheimer's disease
Alzheimer's disease, preclinical
Alzheimer's disease, risk factors in
Alzheimer's disease, treatment of
amyloid beta protein
amyotrophic lateral sclerosis
amyotrophic lateral sclerosis, differential diagnosis
amyotrophic lateral sclerosis, etiology of
amyotrophic lateral sclerosis, prognosis
amyotrophic lateral sclerosis, treatment of
aneurysm
aneurysm, intracranial
aneurysm, intracranial, delayed cerebral ischemia with
aneurysm, intracranial, treatment of
angiotensin II receptor blocker
antibiotics
anticoagulant, treatment
anticoagulant, treatment in CVD
anticonvulsants
antihypertensive
antioxidant
apolipoprotein E
apoptosis
aptiganel
arm weakness
ascorbic acid
aspirin
atherosclerosis, generalized
autonomic dysfunction
axonal degeneration
biologic markers
BiPAP
blacks
blood pressure
body temperature
brain atrophy
brain transplantation
bulbar palsy
bulbar palsy, progressive
burning paresthesia
caffeine
calcium antagonist
calcium antagonist, side effects of
cardiac arrest
cardiac arrest and resuscitation
caspases
CAT scan
CAT scan, abnormal
CAT scan, disappearing lesion on
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, xenon-enhanced
cerebral blood flow
cerebral edema
cerebral embolism
cerebral infarction
cerebral ischemia
cerebrospinal fluid
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, complications with
cerebrovascular accident, neonatal
cerebrovascular accident, pathophysiology
cerebrovascular accident, prevention of
cerebrovascular accident, prognosis in
cerebrovascular accident, severity
cerebrovascular accident, spontaneous improvement after
cerebrovascular accident, surgical treatment of
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, time of presentation
cerebrovascular accident, volume
cerebrovascular accident, work up for
cerebrovascular disease
cerebrovascular disease, risk factors in
cerebrovascular disease, surgical treatment of
cholesterol
cholesterol, LDL
cigarette smoking
citicoline
clinical trials
cognition
coma
controversies in neurology
cooling therapy
coronary artery disease
craniectomy, decompressive
crying, pathologic
DATATOP study
degenerative diseases of CNS
dementia
dementia, cerebrovascular disease causing
dementia, incidence
dementia, prevention of
dementia, treatment of
deprenyl
diabetes mellitus
diet
dimebon
disability, neurological
distal muscle weakness
dopamine agonist
dopamine receptor, D2
drug induced neurologic disorders
dying
dysarthria
dyskinesia, buccal lingual facial
dysphagia
efficacy
embolism
emergencies, neurologic
emergency medical technicians
emotional lability
encephalopathy, post traumatic
endarterectomy, carotid
endarterectomy, carotid-complications of
endarterectomy, carotid-indications for
endarterectomy, carotid-long term results
endarterectomy, carotid-morbidity and mortality with
endovascular therapy
enzyme inhibition
epidemiology of neurology
excitotoxin
fasciculation
fatigue
fever
fibrinolytic agents
fibrinolytic agents, combined IA and IV
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibroblast growth factor
fish
flavonoids
foot drop
free radical
fruits
fumarate
gadolinium
gender
Glasgow coma score
glutamic acid
head injury
head injury, evaluation of
head injury, management of
head injury, pathophysiology of
head injury, prevention
head injury, prognosis in
headache
headache, treatment of
hemodilution
hemorrhage, intracranial, newborn
hemorrhage, periventricular
heparin
heralding manifestation
herpes simplex encephalitis, diagnosis of
histamine-2 receptor blockers
HMGcoA reductase inhibitors
hormone replacement
hospice
hydrocephalus
hyperreflexia
hypertension
hyperthermia
hyperuricemia
hypotension, systemic
hypothermia
hypoxic encephalopathy
iatrogenic neurologic disorders
ibuprofen
immunomodulation
indomethacin
intellectual deficit
intracranial pressure monitoring
intraventricular hemorrhage
intrinsic hand muscles, wasting of
ischemic penumbra
Kleine-Levin syndrome
lacunar infarction
laughing, pathologic
L-dopa
leg weakness, unilateral
Lewy body
Lewy body disease, diffuse
life expectancy
lipid lowering agent
lithium
low birth weight
lubeluzole
magnesium sulfate
melatonin
mental status, evaluation of
middle cerebral artery, occlusion of
migraine, prophylaxis
migraine, treatment of
mild cognitive impairment
minocycline
monoamine oxidase inhibitors
mortality
motor neuron disease
movement disorder, extrapyramidal
MRI
MRI, abnormal
MRI, CAT scan compared to
MRI, cerebrovascular disease
MRI, contrast enhanced
MRI, diffusion weighted
MRI, early changes in CVA
MRI, false negative
MRI, mismatch between perfusion/diffusion
MRI, perfusion
MRS
multiple sclerosis
multiple sclerosis, monosymptomatic
multiple sclerosis, pathogenesis
multiple sclerosis, relapsing
multiple sclerosis, treatment of
multiple sclerosis, treatment of, first attack
muscle wasting, diffuse
N-acetyl-L-aspartic acid
nerve growth factor
neuroendocrinology
neurologic disease
neurologic disease, diagnoses of
neurologic evaluation
neurologic examination
neurologic symptoms
neurologic testing
neuronal cell death
neuropathology
neuropathology, brain
neuropathy
neuroprotective agents
neurotransmitter
nicardipine
nimodipine
NMDA antagonists
NMDA receptors
nonsteroidal anti-inflammatory drug
old age, neurology of
pallidotomy
paresthesias
paresthesias, facial
Parkinson disease
Parkinson disease, diagnosis
Parkinson disease, drug induced
Parkinson disease, early symptoms
Parkinson disease, etiology of
Parkinson disease, nonmotor problems of
Parkinson disease, pathogenesis of
Parkinson disease, prognosis of
Parkinson disease, progression
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinsonism syndrome
pathology
pineal
piracetam
platelet inhibiting drugs
practice guidelines
pravastatin
preclinical
premarin
prevention of neurologic disorders
prognosis
psychological testing
rasagiline
rehabilitation for neurologic disorders
research
respirator
respiratory failure
review article
riluzole
risk factors
risk-benefit assessment
safety
seizure
seizure, treatment of
simvastatin
sinemet
single photon emission computed tomography
sleep
sleep pathology and physiology
smell
sodium-glucoe cotransporter-2 inhibitors
statin therapy
stimulant drugs
streptokinase
stroke unit
stroke, progression of
subarachnoid hemorrhage
subarachnoid hemorrhage, treatment of
subthalamic nucleus
subthalamic nucleus deep brain stimulation
synucleinopathy
tea
tetracycline
thrombolysis, mechanical
tissue plasminogen activator, intravenous
treatment of neurologic disorder
tremor, thalamic stimulation for suppression of
tripping
vasospasm, cerebral
vegetables
vestibular function, tests of
vitamin A
vitamin D
vitamin E
vitamin supplementation
whites
wine
Showing articles 1150 to 1200 of 3460 << Previous Next >>

Natalizumab (Tysabri) Treatment for Relapsing Multiple Sclerosis
The Neurologist 13:182-187, Johnson,K.P., 2007

Progressive Multifocal Leukoencephalopathy After Rituximab in a Case of Non-Hodgkin Lymphoma
Neurol 69:704-706, Kranick,S.M.,et al, 2007

Effect of Early Verus Delayed Interferon Beta-1b Treatment on Disability After a First Clinical Event Suggestive of Multiple Sclerosis: A 3-Year Follow-Up Analysis of the BENEFIT Study
Lancet 370:389-397, Kappos,L.,et al, 2007

Acute Ischemic Stroke
NEJM 357:572-529, Bart van der Worp,H. &van Gijn,J., 2007

Randomized Trial of Intraarterial Infusion of Urokinase Within 6 Hours of Middle Cerebral Artery Stroke: The Middle Cerebral Artery Embolism Local Fibrinolytic Intervention Trial (MELT) Japan
Stroke 38:2633-2639,2627, Ogawa,A.,et al, 2007

Prediction of Hemorrhagic Transformation After Recanalization Therapy Using T2*-Permeability Magnetic Resonance Imaging
Ann Neurol 62:170-176, Bang,O.Y.,et al, 2007

Bleeding Risk Analysis in Stroke Imaging Before ThromboLysis (BRASIL): Pooled Analysis of T2*-Weighted Magnetic Resonance Imaging Data From 570 Patients
Storke 38:2738-2744, Fiehler,J.,et al, 2007

MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke Within and Beyond Established Time Windows
Stroke 38:2640-2645, Schellinger,P.D.,et al, 2007

Discontinuation of Statin Therapy and Clinical and Outcome After Ischemic Stroke
Stroke 38:2652-2657, Colvicchi,F.,et al, 2007

Outcome in Adult Low-Grade Glioma: The Impact of Prognostic Factors and Treatment
Neurol 69:1366-1373, Schiff,D.,et al, 2007

Limbic Encephalitis and Variants: Classification, Diagnosis and Treatment
Neurologist 13:261-271, Tuzun,E. &Dalmau,J., 2007

Segmental Zoster Paresis of Limbs: Report of Three Cases and Review of Literature
Neurologist 13:313-317, Kawajiri,S.,et al, 2007

Salvage Whole Brain Radiotherapy for Recurrent or Refractory Primary CNS Lymphoma
Neurol 69:1178-1182, Hottinger,A.F.,et al, 2007

Lead Poisoning From the Beauty Case: Neurologic Manifestations in an Elderly Woman
Neurol 69:929-930, Fluri,F.,et al, 2007

Intravenous Alteplase for Stroke: Beyond the Guidelines and in Particular Clinical Situations
Stroke 38:2612-2618, De Keyser,J.,et al, 2007

Long-Term Outcome After Thrombolysis in Telemedical Stroke Care
Neurol 69:898-903,819, Schwab,S.,et al, 2007

Intratumoral Hemorrhage After Thrombolsyis in a Patient With Glioblastoma Multiforme
Neurol 69:936, Grimm,S.A. &DeAngelis,L.M., 2007

Daclizumab Phase II Trial in Relapsing and Remitting Multiple Sclerosis
Neurol 69:785-789, Rose,J.W.,et al, 2007

Diagnosis and Treatment of Neuromyelitis Optica
The Neurologist 13:2-11, Wingerchuk,D.M., 2007

An 85-Year-Old Man With Chronic Lymphocytic Leukemia and Altered Mental Status
Neurol 68:460-467, Tyler,K.L.,et al, 2007

Vascultic Neuropathies: An Update
The Neurologist 13:12-19, Gorson,K.C., 2007

Ischemic and Hemorrhagic Complications After Intra-Arterial Fibrinolysis in Vertebrobasilar Occlusion
AJNR 28:378-381, Schulte-Altedorneburg,G.,et al, 2007

Leukoaraiosis and Intracerebral Hemorrhage After Thrombolysis in Acute Stroke
Neurol 68:1020-1024, Palumbo,V.,et al, 2007

Neutralizing Antibodies to Interferon Beta: Assessment of Their Clinical and Radiographic Impact: An Evidence Report
Neurol 68:977-984, Goodin,D.S.,et al, 2007

Clinical Manifestations and Treatment of Rheumatoid Pachymeningitis
Neurol 68:1079-1080, Starosta,M.A. &Brandwein,S.R., 2007

Admission Facility Is Associated With Outcome of Basilar Artery Occlusion
Stroke 38:1380-1383, Muller,R.,et al, 2007

Managing Acute Organophosphorus Pesticide Poisoning
BMJ 334:629-634, Roberts,D.M.&Aaron,C.K., 2007

Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis
JAMA 297:1344-1353,1376, Crouse III,J.R.,et al, 2007

Natalizumab Reduces Visual Loss in Patients with Relapsing Multiple Sclerosis
Neurol 68:1299-1302, Balcer,L.J.,et al, 2007

Anterior Cerebral Artery Emboli in Combined Intravenous and Intra-arterial rtPA Treatment of Acute Ischemic Stroke in the IMS I and II Trials
AJNR 28:1890-1894, King,S.,et al, 2007

Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007

Antiedema Therapy in Ischemic Stroke
Stroke 38:3084-3094, Bardutzky,J. &Schwab,S., 2007

Early Treatment with Prednisolone or Acyclovir in Bells Palsy
NEJM 357:1598-1607,1653, Sullivan,F.M.,et al, 2007

Whipples Disease
NEJM 356:55-66, Fenollar,F.,et al, 2007

Chronic Autoimmune Autonomic neuropathy Responsive to Immunosuppressive Therapy
Neurol 68:161-162, Modoni,A.,et al, 2007

Recanalization After Thrombolysis in Stroke Patients: Predictors and Prognostic Implications
Neurol 68:39-44, Zangerle,A.,et al, 2007

Cost-Effectiveness of Intravenous Thrombolysis With Alteplase Within a 3-Hour Window After Acute Ischemic Stroke
Stroke 38:85-89, Ehlers,L.,et al, 2007

Is Intra-Arterial Thrombolysis Safe After Full-Dose Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke?
Stroke 38:80-84, Shaltoni,H.M.,et al, 2007

Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type in the Canadian Alteplase for Stroke Effectiveness Study Registry
Stroke 38:7579, Dzialowski,I.,et al, 2007

Established Treatments for Acute Ischaemic Stroke
Lancet 369:319-330, Khaja,A.M. &Grotta,J.C., 2007

Thrombolysis With Alteplase for Acute Ischaemic Stroke in the Safe Implementation of Thrombolysis in stroke-Monitoring Study (SITS-MOST): An Observational Study
Lancet 369:275-282,249, Wahlgren,N.,et al, 2007

Identification of the Penumbra and Infarct Core on Hyperacute Noncontrast and Perfusion CT
Neurol 68:730-736,717, Parsons,M.W.,et al, 2007

A 63-Year-Old Man With Headaches and Behavioral Deterioration
Neurol 68:782-787, Greenberg,S.M.,et al, 2007

Comparison of CT Perfusion and Angiography and MRI in Selecting Stroke Patients for Acute Treatment
Neurol 68:694-697, Wintermark,M.,et al, 2007

Facial Weakness in a Haemodialysis Patient
Lancet 369:714, Papadakis,M.,et al, 2007

The Safety of Hospital Stroke Care
Neurol 68:550-555,542, Holloway,R.G.,et al, 2007

Perioperative Stroke
NEJM 356:706-713, Selim,M., 2007

Narrative Review: Reversible Cerebral Vasoconstriction Syndromes
Ann Intern Med 146:34-44, Calabrese,L.H.,et al, 2007

Gadolinium-Based MR Contrast Agents and Nephrogenic Systemic Fibrosis
Radiology 242:647-649, Kuo,P.H.,et al, 2007

Chemotheraphy for Low-Grade Gliomas: Emering Consensus on Its Benefits
Neurol 68:1762-1763, Wen,P.Y. &DeAngelis,L.M., 2007



Showing articles 1150 to 1200 of 3460 << Previous Next >>